[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Androgenic Alopecia Drug Market Report 2018

March 2018 | 101 pages | ID: U8808996BB9QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Androgenic Alopecia Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Androgenic Alopecia Drug in these regions, from 2013 to 2025 (forecast).
United States Androgenic Alopecia Drug market competition by top manufacturers/players, with Androgenic Alopecia Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Allergan, Inc.
  • Histogen, Inc.
  • R-Tech Ueno, Ltd.
  • Hygeia Therapeutics, Inc.
  • SWITCH Biotech LLC
  • Polichem S.A.
  • Kasiak Research Pvt. Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • RK-023
  • Refagro
  • RCH-01
  • SM-04554
  • HYG-440
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Home Use
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Androgenic Alopecia Drug Market Report 2018

1 ANDROGENIC ALOPECIA DRUG OVERVIEW

1.1 Product Overview and Scope of Androgenic Alopecia Drug
1.2 Classification of Androgenic Alopecia Drug by Product Category
  1.2.1 United States Androgenic Alopecia Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Androgenic Alopecia Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 RK-023
  1.2.4 Refagro
  1.2.5 RCH-01
  1.2.6 SM-04554
  1.2.7 HYG-440
  1.2.8 Others
1.3 United States Androgenic Alopecia Drug Market by Application/End Users
  1.3.1 United States Androgenic Alopecia Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Home Use
1.4 United States Androgenic Alopecia Drug Market by Region
  1.4.1 United States Androgenic Alopecia Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Androgenic Alopecia Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Androgenic Alopecia Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Androgenic Alopecia Drug Status and Prospect (2013-2025)
  1.4.5 New England Androgenic Alopecia Drug Status and Prospect (2013-2025)
  1.4.6 The South Androgenic Alopecia Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Androgenic Alopecia Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Androgenic Alopecia Drug (2013-2025)
  1.5.1 United States Androgenic Alopecia Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Androgenic Alopecia Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES ANDROGENIC ALOPECIA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Androgenic Alopecia Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Androgenic Alopecia Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Androgenic Alopecia Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Androgenic Alopecia Drug Market Competitive Situation and Trends
  2.4.1 United States Androgenic Alopecia Drug Market Concentration Rate
  2.4.2 United States Androgenic Alopecia Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Androgenic Alopecia Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANDROGENIC ALOPECIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Androgenic Alopecia Drug Sales and Market Share by Region (2013-2018)
3.2 United States Androgenic Alopecia Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Androgenic Alopecia Drug Price by Region (2013-2018)

4 UNITED STATES ANDROGENIC ALOPECIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Androgenic Alopecia Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Androgenic Alopecia Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Androgenic Alopecia Drug Price by Type (2013-2018)
4.4 United States Androgenic Alopecia Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ANDROGENIC ALOPECIA DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Androgenic Alopecia Drug Sales and Market Share by Application (2013-2018)
5.2 United States Androgenic Alopecia Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANDROGENIC ALOPECIA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan, Inc. Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Histogen, Inc.
  6.2.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Histogen, Inc. Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 R-Tech Ueno, Ltd.
  6.3.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 R-Tech Ueno, Ltd. Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Hygeia Therapeutics, Inc.
  6.4.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 SWITCH Biotech LLC
  6.5.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 SWITCH Biotech LLC Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Polichem S.A.
  6.6.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Polichem S.A. Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Kasiak Research Pvt. Ltd.
  6.7.2 Androgenic Alopecia Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 ANDROGENIC ALOPECIA DRUG MANUFACTURING COST ANALYSIS

7.1 Androgenic Alopecia Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Androgenic Alopecia Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Androgenic Alopecia Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Androgenic Alopecia Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANDROGENIC ALOPECIA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Androgenic Alopecia Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Androgenic Alopecia Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Androgenic Alopecia Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Androgenic Alopecia Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Androgenic Alopecia Drug
Figure United States Androgenic Alopecia Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Androgenic Alopecia Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure RK-023 Product Picture
Figure Refagro Product Picture
Figure RCH-01 Product Picture
Figure SM-04554 Product Picture
Figure HYG-440 Product Picture
Figure Others Product Picture
Figure United States Androgenic Alopecia Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Androgenic Alopecia Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure United States Androgenic Alopecia Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Androgenic Alopecia Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Androgenic Alopecia Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Androgenic Alopecia Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Androgenic Alopecia Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Androgenic Alopecia Drug Sales Share by Players/Suppliers
Figure 2017 United States Androgenic Alopecia Drug Sales Share by Players/Suppliers
Figure United States Androgenic Alopecia Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Androgenic Alopecia Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Androgenic Alopecia Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Androgenic Alopecia Drug Revenue Share by Players/Suppliers
Figure 2017 United States Androgenic Alopecia Drug Revenue Share by Players/Suppliers
Table United States Market Androgenic Alopecia Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Androgenic Alopecia Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Androgenic Alopecia Drug Market Share of Top 3 Players/Suppliers
Figure United States Androgenic Alopecia Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Androgenic Alopecia Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Androgenic Alopecia Drug Product Category
Table United States Androgenic Alopecia Drug Sales (K Pcs) by Region (2013-2018)
Table United States Androgenic Alopecia Drug Sales Share by Region (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Share by Region (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Market Share by Region in 2017
Table United States Androgenic Alopecia Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Androgenic Alopecia Drug Revenue Share by Region (2013-2018)
Figure United States Androgenic Alopecia Drug Revenue Market Share by Region (2013-2018)
Figure United States Androgenic Alopecia Drug Revenue Market Share by Region in 2017
Table United States Androgenic Alopecia Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Androgenic Alopecia Drug Sales (K Pcs) by Type (2013-2018)
Table United States Androgenic Alopecia Drug Sales Share by Type (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Share by Type (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Market Share by Type in 2017
Table United States Androgenic Alopecia Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Androgenic Alopecia Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Androgenic Alopecia Drug by Type (2013-2018)
Figure Revenue Market Share of Androgenic Alopecia Drug by Type in 2017
Table United States Androgenic Alopecia Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Growth Rate by Type (2013-2018)
Table United States Androgenic Alopecia Drug Sales (K Pcs) by Application (2013-2018)
Table United States Androgenic Alopecia Drug Sales Market Share by Application (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Market Share by Application (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Market Share by Application in 2017
Table United States Androgenic Alopecia Drug Sales Growth Rate by Application (2013-2018)
Figure United States Androgenic Alopecia Drug Sales Growth Rate by Application (2013-2018)
Table Allergan, Inc. Basic Information List
Table Allergan, Inc. Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan, Inc. Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure Allergan, Inc. Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure Allergan, Inc. Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table Histogen, Inc. Basic Information List
Table Histogen, Inc. Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Histogen, Inc. Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure Histogen, Inc. Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure Histogen, Inc. Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table R-Tech Ueno, Ltd. Basic Information List
Table R-Tech Ueno, Ltd. Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure R-Tech Ueno, Ltd. Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure R-Tech Ueno, Ltd. Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure R-Tech Ueno, Ltd. Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table Hygeia Therapeutics, Inc. Basic Information List
Table Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table SWITCH Biotech LLC Basic Information List
Table SWITCH Biotech LLC Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure SWITCH Biotech LLC Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure SWITCH Biotech LLC Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure SWITCH Biotech LLC Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table Polichem S.A. Basic Information List
Table Polichem S.A. Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Polichem S.A. Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure Polichem S.A. Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure Polichem S.A. Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table Kasiak Research Pvt. Ltd. Basic Information List
Table Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Sales Growth Rate (2013-2018)
Figure Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Sales Market Share in United States (2013-2018)
Figure Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgenic Alopecia Drug
Figure Manufacturing Process Analysis of Androgenic Alopecia Drug
Figure Androgenic Alopecia Drug Industrial Chain Analysis
Table Raw Materials Sources of Androgenic Alopecia Drug Major Players/Suppliers in 2017
Table Major Buyers of Androgenic Alopecia Drug
Table Distributors/Traders List
Figure United States Androgenic Alopecia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Androgenic Alopecia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Androgenic Alopecia Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Androgenic Alopecia Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Androgenic Alopecia Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Androgenic Alopecia Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Androgenic Alopecia Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories